Regeneron Pharmaceuticals (REGN)

Add to Watchlists
Create an Alert
427.46 +3.67  +0.86% NASDAQ Dec 19, 10:51AM BATS Real time Currency in USD
View Full Chart
REGN Price Chart
View All Events

REGN Events

Date Type Description
11/04/2014 08:30 EST Misc Q3 2014 Regeneron Pharmaceuticals Inc Earnings Conference Call
11/04/2014 Earnings Q3 2014 Regeneron Pharmaceuticals Inc Earnings Results
08/05/2014 08:30 EDT Misc Q2 2014 Regeneron Pharmaceuticals Inc Earnings Conference Call
08/05/2014 Earnings Q2 2014 Regeneron Pharmaceuticals Inc Earnings Results
06/13/2014 Misc Annual General Meeting for Regeneron Pharmaceuticals Inc
05/08/2014 08:30 EDT Misc Regeneron Pharmaceuticals Q1 2014 Earnings Conference Call
05/08/2014 Earnings Regeneron Pharmaceuticals Q1 2014 Earnings Results
02/11/2014 08:30 EST Misc Regeneron to Report Fourth Quarter and Full Year 2013 Financial Conference Call
02/11/2014 Earnings Regeneron to Report Fourth Quarter and Full Year 2013 Financial and Operating Results
View All Performance Charts

REGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Regeneron Pharmaceuticals is up 57.31% over the last year vs S&P 500 Total Return up 16.45%, Vertex Pharmaceuticals up 76.85%, and Amgen up 52.31%.

Get Quote for

PDF Report for REGN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download REGN Pro Report PDF
Advertisement

Portfolio Strategies Featuring REGN

Did Regeneron Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

REGN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.regeneron.com
  • IR Website: http://investor.regeneron.com/
  • HQ Country: United States
  • HQ State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: New York
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: September 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Regeneron Pharmaceuticals Inc is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

REGN Excel Add-In Codes

  • Name: =YCI("REGN","name")
  • Description: =YCI("REGN","description")
  • Sector: =YCI("REGN","sector")
  • Industry: =YCI("REGN","industry")
  • Est. Current Fiscal Year End: =YCI("REGN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.